Anonymous
Guest
Anonymous
Guest
Why would anyone use Vesi or Myrb with a generic DLA available? We don't have any useful clinical data to support our message, but we're being asked to grow Trx and ms. This is just crazy?
Hire inapt people and you get what you deserve. The culture is now just like David Boyd. A loser.
Big pharma rejects hired at senior management levels poisoned the culture years ago. Place is full of "yes men" to the Japs and old Fuji burnouts now. Useless.
Why do we have to put up with so much bs here. Our only competition in just about every category are generics and we're holding on to every Rx we can. If we only had some new and relevant drugs to sell, this place might not be in the toilet. I can't remember the last time we saw a presentation on our pipeline or any R&D for that matter. What's the deal??
This was once an up-and-coming company, but in the past few years we've completely lost our way. No new products, other than launching a few dogs, and other companies are making exciting deals for the future. With all the M & A activity going on, Astellas is never in the picture or even mentioned! We are on the outside looking in and no one at HQ seems to give a shit.
How did we get so far off-track? Sure we make money, but it is getting more difficult to sell products with 90%+ ms without going off-label and there is no hope for anything in our pipeline. Hope something changes soon or it's time to go!